Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants.

Rubin RR, Knowler WC, Ma Y, Marrero DG, Edelstein SL, Walker EA, Garfield SA, Fisher EB; Diabetes Prevention Program Research Group..

Diabetes Care. 2005 Apr;28(4):830-7.

2.

Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.

Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE, Haffner SM, Price DW, Knowler WC; Diabetes Prevention Program Research Group..

Diabetes Care. 2008 Mar;31(3):420-6.

3.

Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.

Marrero DG, Ma Y, de Groot M, Horton ES, Price DW, Barrett-Connor E, Carnethon MR, Knowler WC; Diabetes Prevention Program Research Group..

Psychosom Med. 2015 Apr;77(3):303-10. doi: 10.1097/PSY.0000000000000156.

4.

Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.

Rubin RR, Gaussoin SA, Peyrot M, DiLillo V, Miller K, Wadden TA, West DS, Wing RR, Knowler WC; Look AHEAD Research Group..

Diabetologia. 2010 Aug;53(8):1581-9. doi: 10.1007/s00125-010-1765-1.

5.

Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.

Rubin RR, Peyrot M, Gaussoin SA, Espeland MA, Williamson D, Faulconbridge LF, Wadden TA, Ewing L, Safford M, Evans-Hudnall G, Wing RR, Knowler WC; Look AHEAD Research Group..

Diabetes Care. 2013 May;36(5):1088-94. doi: 10.2337/dc12-1871.

6.

Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program.

Price DW, Ma Y, Rubin RR, Perreault L, Bray GA, Marrero D, Knowler WC, Barrett-Connor E, Lacoursiere DY; Diabetes Prevention Program Research Group..

Diabetes Care. 2013 Feb;36(2):216-21. doi: 10.2337/dc12-0293.

7.

Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial.

Rubin RR, Wadden TA, Bahnson JL, Blackburn GL, Brancati FL, Bray GA, Coday M, Crow SJ, Curtis JM, Dutton G, Egan C, Evans M, Ewing L, Faulconbridge L, Foreyt J, Gaussoin SA, Gregg EW, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Knowler WC, Lang W, Lewis CE, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Rejeski WJ, Rosenthal RH, Ruelas V, Toledo K, Van Dorsten B, Vitolins M, Williamson D, Wing RR, Yanovski SZ, Zhang P; Look AHEAD Research Group..

Diabetes Care. 2014 Jun;37(6):1544-53. doi: 10.2337/dc13-1928.

8.

Prevalence and correlates of depression in individuals with and without type 1 diabetes.

Gendelman N, Snell-Bergeon JK, McFann K, Kinney G, Paul Wadwa R, Bishop F, Rewers M, Maahs DM.

Diabetes Care. 2009 Apr;32(4):575-9. doi: 10.2337/dc08-1835.

9.

Factors associated with depressive symptoms and use of antidepressant medications among participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC Studies.

Fischer MJ, Xie D, Jordan N, Kop WJ, Krousel-Wood M, Kurella Tamura M, Kusek JW, Ford V, Rosen LK, Strauss L, Teal VL, Yaffe K, Powe NR, Lash JP; CRIC Study Group Investigators..

Am J Kidney Dis. 2012 Jul;60(1):27-38. doi: 10.1053/j.ajkd.2011.12.033.

10.

Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study.

Rubin RR, Ma Y, Peyrot M, Marrero DG, Price DW, Barrett-Connor E, Knowler WC; Diabetes Prevention Program Research Group..

Diabetes Care. 2010 Dec;33(12):2549-51. doi: 10.2337/dc10-1033.

11.

Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program.

Perreault L, Ma Y, Dagogo-Jack S, Horton E, Marrero D, Crandall J, Barrett-Connor E; Diabetes Prevention Program..

Diabetes Care. 2008 Jul;31(7):1416-21. doi: 10.2337/dc07-2390.

12.

Diagnosis of depression and use of antidepressant pharmacotherapy among adults in the United States: does a disparity persist by ethnicity/race?

Sclar DA, Robison LM, Schmidt JM, Bowen KA, Castillo LV, Oganov AM.

Clin Drug Investig. 2012 Feb 1;32(2):139-44. doi: 10.2165/11598950-000000000-00000.

PMID:
22220929
13.

Prevalence and correlates of depressive disorders in elderly with type 2 diabetes in primary health care settings.

Shehatah A, Rabie MA, Al-Shahry A.

J Affect Disord. 2010 Jun;123(1-3):197-201. doi: 10.1016/j.jad.2009.09.002.

PMID:
19804911
14.

Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program.

Mather KJ, Funahashi T, Matsuzawa Y, Edelstein S, Bray GA, Kahn SE, Crandall J, Marcovina S, Goldstein B, Goldberg R; Diabetes Prevention Program..

Diabetes. 2008 Apr;57(4):980-6. doi: 10.2337/db07-1419.

15.

Racial disparities in the treatment of depression in low-income persons with diabetes.

Osborn CY, Trott HW, Buchowski MS, Patel KA, Kirby LD, Hargreaves MK, Blot WJ, Cohen SS, Schlundt DG.

Diabetes Care. 2010 May;33(5):1050-4. doi: 10.2337/dc09-1929.

16.

Effects of eliminating drug caps on racial differences in antidepressant use among dual enrollees with diabetes and depression.

Adams AS, Soumerai SB, Zhang F, Gilden D, Burns M, Huskamp HA, Trinacty C, Alegria M, LeCates RF, Griggs JJ, Ross-Degnan D, Madden JM.

Clin Ther. 2015 Mar 1;37(3):597-609. doi: 10.1016/j.clinthera.2014.12.011.

18.

An update on the Diabetes Prevention Program.

Ratner RE; Diabetes Prevention Program Research..

Endocr Pract. 2006 Jan-Feb;12 Suppl 1:20-4. Review.

19.

Depression and obesity in the U.S. adult household population, 2005-2010.

Pratt LA, Brody DJ.

NCHS Data Brief. 2014 Oct;(167):1-8.

20.

Achieving weight and activity goals among diabetes prevention program lifestyle participants.

Wing RR, Hamman RF, Bray GA, Delahanty L, Edelstein SL, Hill JO, Horton ES, Hoskin MA, Kriska A, Lachin J, Mayer-Davis EJ, Pi-Sunyer X, Regensteiner JG, Venditti B, Wylie-Rosett J; Diabetes Prevention Program Research Group..

Obes Res. 2004 Sep;12(9):1426-34.

Items per page

Supplemental Content

Support Center